Breaking News Instant updates and real-time market news.

SLS

Sellas Life Sciences

$3.66

0.1 (2.81%)

09:02
01/13/20
01/13
09:02
01/13/20
09:02

Sellas Life Sciences announces 2020 clinical milestones

Expected 2020 Clinical Milestones First patient dosed in the Phase 3 registration-enabling study of GPS in AML patients in February 2020. First patient dosed in the Phase 1 open-label study of GPS with nivolumab in MPM patients in January 2020. Interim analysis of the Phase 1/2 basket study of GPS with pembrolizumab in multiple tumor types in the second half of 2020. Guidance from the FDA on the regulatory and development pathway for NPS in TNBC patients in the first quarter of 2020. Initial data from Phase 2 trial of NPS in DCIS in the first quarter of 2020.

  • 13

    Jan

SLS Sellas Life Sciences
$3.66

0.1 (2.81%)

03/22/19
MAXM
03/22/19
DOWNGRADE
MAXM
Hold
Sellas Life Sciences downgraded to Hold from Buy at Maxim
03/25/19
03/25/19
DOWNGRADE

Hold
Sellas Life Sciences downgraded to Hold from Buy at Maxim
As previously reported, Maxim analyst Jason McCarthy downgraded Sellas Life Sciences to Hold, saying the company's "tight" cash balance will likely require it to raise capital to support the planned Phase 3 study of galinpepimut-S, or GPS. The analyst maintains however that Sellas Life Sciences fundamentals remain intact, and his positive views around GPS and Nelipepimut-S, or NPS, remain unchanged.
04/08/19
04/08/19
INITIATION
Target $4.5

Buy
Sellas Life Sciences initiated with a Buy at Alliance Global Partners
Alliance Global Partners analyst James Molloy initiated Sellas Life Sciences with a Buy and $4.50 price target.
11/15/19
MAXM
11/15/19
UPGRADE
Target $12
MAXM
Buy
Sellas Life Sciences upgraded to Buy from Hold at Maxim
Maxim analyst Jason McCarthy upgraded Sellas Life Sciences to Buy from Hold with a $12 price target after its Q3 results. The analyst notes that the company has ended with $9.1M in cash, which should be enough to fund it through the first half of 2020 and sufficient to reach the next set of catalysts. McCarthy adds that he remains positive on the company's cancer vaccine platform, with the basis of his prior Hold rating being his concerns with Sellas' capital levels. The analyst further states that the next key event for the company is initiating the phase 3 program of galinpepimut-S, expected before year-end 2019.

TODAY'S FREE FLY STORIES

QSR

Restaurant Brands

$65.41

0.085 (0.13%)

, TAST

Carrols Restaurant

$5.01

-0.1 (-1.96%)

14:55
01/22/20
01/22
14:55
01/22/20
14:55
Periodicals
Burger King cutting Impossible Whopper price as sales slow, Bloomberg says »

Burger King, a Restaurant…

QSR

Restaurant Brands

$65.41

0.085 (0.13%)

TAST

Carrols Restaurant

$5.01

-0.1 (-1.96%)

BYND

Beyond Meat

$124.60

-4.64 (-3.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$4.96

0.81 (19.52%)

14:51
01/22/20
01/22
14:51
01/22/20
14:51
Recommendations
Express analyst commentary  »

Wedbush…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

BYND

Beyond Meat

$125.41

-3.83 (-2.96%)

, QSR

Restaurant Brands

$65.43

0.105 (0.16%)

14:51
01/22/20
01/22
14:51
01/22/20
14:51
Periodicals
Burger King cutting Impossible Whopper price as sales slow, Bloomberg says »

Shares of Beyond Meat,…

BYND

Beyond Meat

$125.41

-3.83 (-2.96%)

QSR

Restaurant Brands

$65.43

0.105 (0.16%)

TAST

Carrols Restaurant

$5.02

-0.09 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$21.04

0.11 (0.53%)

14:49
01/22/20
01/22
14:49
01/22/20
14:49
Options
Kinder Morgan options imply 2.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

VZ

Verizon

$60.68

0.36 (0.60%)

, GOOG

Alphabet

$1,493.50

8.58 (0.58%)

14:43
01/22/20
01/22
14:43
01/22/20
14:43
Hot Stocks
Verizon partners with Google Stadia for cloud gaming »

"It's no…

VZ

Verizon

$60.68

0.36 (0.60%)

GOOG

Alphabet

$1,493.50

8.58 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 03

    Feb

MDC

M.D.C. Holdings

$43.74

0.51 (1.18%)

14:39
01/22/20
01/22
14:39
01/22/20
14:39
Hot Stocks
Richmond American Homes plans to acquire 1,000 sites at Aurora Highlands »

Richmond American Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

CHCO

City Holding

$80.65

0.14 (0.17%)

14:32
01/22/20
01/22
14:32
01/22/20
14:32
Hot Stocks
City Holding announces pre-tax gain of $17.8M on sale of Visa Class B shares »

City Holding Company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMA

Comerica

$66.49

0.19 (0.29%)

14:31
01/22/20
01/22
14:31
01/22/20
14:31
Hot Stocks
Comerica names Melinda Chausse chief credit officer »

Comerica announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Feb

AAOI

Applied Optoelectronics

$14.23

0.51 (3.72%)

14:25
01/22/20
01/22
14:25
01/22/20
14:25
Options
Applied Optoelectronics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$126.65

0.54 (0.43%)

, UNP

Union Pacific

$181.23

-1.27 (-0.70%)

14:22
01/22/20
01/22
14:22
01/22/20
14:22
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$126.65

0.54 (0.43%)

UNP

Union Pacific

$181.23

-1.27 (-0.70%)

KMB

Kimberly-Clark

$145.50

0.91 (0.63%)

VFC

VF Corp.

$95.12

0.49 (0.52%)

LUV

Southwest

$53.64

0.1 (0.19%)

MTB

M&T Bank

$162.54

1.655 (1.03%)

KEY

KeyCorp

$19.61

0.11 (0.56%)

HBAN

Huntington Bancshares

$14.84

0.22 (1.51%)

AAL

American Airlines

$27.50

0.29 (1.07%)

JBLU

JetBlue

$19.90

0.81 (4.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 17

    Feb

  • 04

    Mar

TXN

Texas Instruments

$133.66

2.81 (2.15%)

, KMI

Kinder Morgan

$21.05

0.12 (0.57%)

14:22
01/22/20
01/22
14:22
01/22/20
14:22
Earnings
Notable companies reporting after market close »

Notable companies…

TXN

Texas Instruments

$133.66

2.81 (2.15%)

KMI

Kinder Morgan

$21.05

0.12 (0.57%)

CTXS

Citrix

$119.46

1.67 (1.42%)

TER

Teradyne

$73.17

1.64 (2.29%)

PTC

PTC

$79.86

0.93 (1.18%)

STLD

Steel Dynamics

$32.05

0.14 (0.44%)

SLM

Sallie Mae

$9.15

0.31 (3.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 29

    Jan

  • 12

    Feb

  • 26

    Feb

XOM

Exxon Mobil

$67.01

-0.58 (-0.86%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Periodicals
Exxon Mobil set to kick off U.K., Germany asset sales, Bloomberg says »

Exxon Mobil intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

CHEOY

Cochlear

$0.00

(0.00%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Downgrade
Cochlear rating change  »

Cochlear downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
01/22/20
01/22
14:16
01/22/20
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPG

Simon Property

$146.15

-2.96 (-1.99%)

14:15
01/22/20
01/22
14:15
01/22/20
14:15
Options
Simon Property put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

FCEL

FuelCell

$2.15

-0.725 (-25.26%)

, PKX

Posco

$51.39

-0.15 (-0.29%)

14:14
01/22/20
01/22
14:14
01/22/20
14:14
On The Fly
FuelCell plunges on bigger than expected loss, revenue miss »

Shares of FuelCell (FCEL)…

FCEL

FuelCell

$2.15

-0.725 (-25.26%)

PKX

Posco

$51.39

-0.15 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 31

    Jan

NK

NantKwest

$5.94

-0.32 (-5.11%)

14:14
01/22/20
01/22
14:14
01/22/20
14:14
Hot Stocks
Breaking Hot Stocks news story on NantKwest 

NantKwest trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NK

NantKwest

$5.90

-0.36 (-5.75%)

14:09
01/22/20
01/22
14:09
01/22/20
14:09
Hot Stocks
Breaking Hot Stocks news story on NantKwest »

NantKwest trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRP

Neurotrope

$2.73

1.3 (90.91%)

14:08
01/22/20
01/22
14:08
01/22/20
14:08
Syndicate
Neurotrope announces $18M registered direct offering »

Neurotrope announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$222.17

0.69 (0.31%)

, TWTR

Twitter

$34.34

0.25 (0.73%)

14:05
01/22/20
01/22
14:05
01/22/20
14:05
On The Fly
#SocialStocks: No ads in WhatsApp, No edit button for Twitter »

Welcome to…

FB

Facebook

$222.17

0.69 (0.31%)

TWTR

Twitter

$34.34

0.25 (0.73%)

SNAP

Snap

$19.25

0.24 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 29

    Jan

  • 04

    Feb

  • 06

    Feb

MPLX

MPLX

$25.13

-0.54 (-2.10%)

14:05
01/22/20
01/22
14:05
01/22/20
14:05
Options
MPLX call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BA

Boeing

$310.94

-2.37 (-0.76%)

14:04
01/22/20
01/22
14:04
01/22/20
14:04
Periodicals
Boeing CEO says 737 MAX return delayed due to simulator training, CNBC reports »

Boeing CEO Dave Calhoun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

CNCE

Concert Pharmaceuticals

$10.86

1.04 (10.59%)

14:04
01/22/20
01/22
14:04
01/22/20
14:04
Recommendations
Concert Pharmaceuticals analyst commentary  »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$311.75

-1.56 (-0.50%)

13:58
01/22/20
01/22
13:58
01/22/20
13:58
Periodicals
Boeing aims to resume 737 MAX production before return to service, CNBC says »

Dave Calhoun, the new CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.